Trial Profile
Randomized Phase II trial of TS-1 based thrapy vs TS-1 based therapy + LNT for advanced or Recurrent Gastric Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Jul 2018
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Lentinan (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 02 Jul 2018 Status changed from not yet recruiting to discontinued.
- 05 Jun 2018 New trial record